10-Bromo-1-aminodecane, hydrobromide - CAS 24566-82-3
Catalog number: 24566-82-3
Category: Main Product
Molecular Formula:
C10H23Br2N
Molecular Weight:
317.1
COA:
Inquire
Purity:
95%
Appearance:
Off-White to Pale Beige Solid
Synonyms:
10-BROMO-1-AMINODECANE, HYDROBROMIDE
MSDS:
Inquire
Quantity:
Data not available, please inquire.
InChIKey:
ZWGBEXOWJAAGPB-UHFFFAOYSA-N
InChI:
InChI=1S/C10H22BrN.BrH/c11-9-7-5-3-1-2-4-6-8-10-12;/h1-10,12H2;1H
Canonical SMILES:
C(CCCCCBr)CCCCN.Br
1.Single-dose pharmacokinetics of bupropion hydrobromide and metabolites in healthy adolescent and adult subjects.
Oh DA1, Crean CS1. Clin Pharmacol Drug Dev. 2015 Sep;4(5):346-353. doi: 10.1002/cpdd.195. Epub 2015 Jul 20.
Data from 2 pediatric single-dose studies, conducted at the same center, were combined to evaluate exposure levels of bupropion and metabolites in adolescents 12-17 years old, compared with adults > 18 years. Pharmacokinetic analyses of bupropion and its metabolites were performed using normalization and pharmacological/convulsive weighting methods on exposure. When compared with adults (>18 years), subjects 12-14 years had an increase in weight-normalized exposure to bupropion (ie, Cmax , 78%; AUC0-t , 83%; and AUCinf , 85%). Variability in this younger age group was also higher, with observations of a 3- to 4-fold increase in exposure. When the changes in metabolites were accounted within pharmacological and convulsive-weighted exposures, the relative ratio of 12-14 years to adults in body weight-normalized Cmax was 127% and 110%, respectively. Subjects 15-17 years did not exhibit a difference in exposure compared with adults. The influence of age on bupropion pharmacokinetics demonstrates that, in general, healthy adolescent subjects cannot be considered smaller healthy adult subjects; the increase in exposure is inversely related to age and appears to be solely associated with bupropion, not with its metabolites.
2.Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide.
Shelke S1, Shahi S2, Jadhav K3, Dhamecha D3, Tiwari R4, Patil H4. J Mater Sci Mater Med. 2016 Jun;27(6):103. doi: 10.1007/s10856-016-5713-6. Epub 2016 Apr 18.
The objective of the current study was to formulate and characterize thermoreversible gel of Eletriptan Hydrobromide for brain targeting via the intranasal route. Ethosomes were prepared by 3(2) factorial design with two independent variables (concentration of soya lecithin and ethanol) and two response variables [percent entrapment efficiency and vesicle size (nm)] using ethanol injection method. Formulated ethosomes were evaluated for preliminary microscopic examination followed by percent drug entrapment efficiency, vesicle size analysis, zeta potential, polydispersibility index and Transmission electron microscopy (TEM). TEM confirms spherical morphology of ethosomes, whereas Malvern zeta sizer confirms that the vesicle size was in the range of 191 ± 6.55-381.3 ± 61.0 nm. Ethosomes were incorporated in gel using poloxamer 407 and carbopol 934 as thermoreversible and mucoadhesive polymers, respectively. Ethosomal gels were evaluated for their pH, viscosity, mucoadhesive strength, in vitro drug release and ex vivo drug permeation through the sheep nasal mucosa.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


Chemical Structure

CAS 24566-82-3 10-Bromo-1-aminodecane, hydrobromide

Quick Inquiry

Verification code

Featured Items